最新更新 :
19/11/2024
Infostab
薬剤一覧
まとめ一覧
互換性の検索
Yサイト対応表
引用文献
研究チーム
valistab
ポスター
接続
スポンサー
作成者
ユーザーガイド
ニュースレター
Vinblastine sulfate
化学構造
商品名
商品名、賦形剤は国、製薬会社ごとに異なることがあります
Blestinib
メキシコ
Cytoblastin
エジプト, マレーシア
Lemblastine
コロンビア, チリ, メキシコ
Oncoblastin
コロンビア
Uniblastin
ペルー
VBlastin
インド
Velbe
アラブ首長国連邦, アーストラリア, イギリス, イタリア, オランダ, オーストリア, ギリシア, サウジアラビア, スイス, スウェーデン, チリ, デンマーク, ノルウェー, フィンランド, フランス, モロッコ, ルクセンブルグ
Velblastin
エジプト, マレーシア
Vinblasine
ルクセンブルグ
Vinblastin
ハンガリー, ポーランド
Vinblastina
アルゼンチン, エクアドル, コロンビア, スペイン, チリ, ペルー, メキシコ, ルーマニア
Vinblastine
アイルランド, アメリカ, アーストラリア, イギリス, イラン, オランダ, カナダ, サウジアラビア, チュニジア, ニュージーランド, フランス, ベルギー
Vinblastinsulfat
ドイツ
Vinblatine
マレーシア
Vinko
トルコ
引用文献 : Vinblastine sulfate
形式
出版物
3
雑誌
Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
81
雑誌
Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84
雑誌
Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
99
雑誌
Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
144
雑誌
Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML.
Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags.
Int J Pharm 1991 ; 77: 279-285.
167
雑誌
Francomb MM, Ford JL, Lee MG.
Adsorption of vincristine, vinblastine, doxorubicin and mitoxantrone to in-line intravenous filters.
Int J Pharm 1994 ; 103: 87-92.
169
雑誌
Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244
雑誌
Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
248
雑誌
Trissel LA, Martinez JF.
Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
Am J Hosp Pharm 1993 ; 50: 300-304.
249
雑誌
Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
307
雑誌
Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
334
雑誌
Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335
雑誌
Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
481
雑誌
Beijnen JH, Vendrig DEMM, Underberg WJM.
Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids.
J Parenter Sci Technol 1989 ; 43: 84-87.
492
雑誌
Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
763
雑誌
Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH.
Drug precipitation within IV tubing : A potential hazard of chemotherapy administration.
Cancer Treat Rep 1985 ; 69: 1325-1326.
827
雑誌
Black J, Buechter DD, Thurston DE.
Stability of vinblastine sulfate when exposed to light.
Drug Intell Clin Pharm 1988 ; 22: 634-636.
905
雑誌
Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
921
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1009
雑誌
Black J, Buechter DD, Chinn JW, Gard J, Thurston DE.
Studies on the stability of vinblastine sulfate in aqueous solution.
J Pharm Sci 1988 ; 77: 630-634.
1157
雑誌
Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM.
Degradation kinetics of vinblastine sulphate in aqueous solutions.
Int J Pharm 1988 ; 43: 131-138.
1229
雑誌
Weir PJ, Ireland DS.
Chemical stability of cytarabine and vinblastine injections.
Br J Pharm Pract 1990 ; 12: 53-54, 60.
1410
雑誌
Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1423
雑誌
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1625
雑誌
Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1727
雑誌
Mittner A, Vincze Z, Jemnitz K.
Stability of vinblastine sulphate containing infusions.
Pharmazie 1999 ; 54: 625-626.
1953
雑誌
Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
3540
実験
Heparin sodium - Summary of Product Characteristics.
Wockhardt 2010
3578
実験
Cisplatin - Summary of Product Characteristics
Accord Healthcare 2011
3644
実験
Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
Mentions Légales